Complete Filing Data
Cantor Equity Partners I, Inc. reported Stockholders Equity of -$16.78 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Cantor Equity Partners I, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income Loss | -$6.7M | -$84.4K | -$3.5K |
| General And Administrative Expense | $855.5K | $84.4K | $3.5K |
| Operating Income Loss | -$973.6K | -$84.4K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|
| Net Income Loss | $1.2M | $2.0M | $993.4K | -$14.0K | -$43.3K |
| General And Administrative Expense | $358.2K | $144.4K | $164.5K | $14.0K | $43.3K |
| Operating Income Loss | -$388.2K | -$174.4K | -$192.5K | -$14.0K | -$43.3K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Stockholders Equity | -$16.8M | -$81.7K | $2.7K | $6.2K |
| Retained Earnings Accumulated Deficit | -$16.8M | -$106.7K | -$22.3K | |
| Liabilities And Stockholders Equity | $207.7M | $217.6K | $2.7K | |
| Assets | $207.7M | $217.6K | $2.7K | |
| Liabilities | $14.0M | $299.3K | ||
| Accrued Liabilities Current | $314.8K | $165.0K | ||
| Temporary Equity Accretion To Redemption Value | $15.0M | |||
| Repayments Of Related Party Debt | $848.9K | |||
| Repayments Of Notes Payable | $134.2K | |||
| Liabilities Current | $800.3K | $299.3K | ||
| Deferred Offering Costs Included In Accrued Expenses | $231.8K | |||
| Deferred Costs | $217.6K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $25.0K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $25.0K | |||
| Assets Held In Trust Noncurrent | $207.5M | |||
| Assets Current | $211.7K | |||
| Other Assets Noncurrent | $3.5K | |||
| Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 | $151.5K | |||
| Forward Sale Securities Liability | $13.2M | |||
| Noncash Or Part Noncash Acquisition Deferred Offering Costs Included In Accrued Expenses | $151.5K | |||
| Deferred Costs Current | $217.6K | |||
| Cash And Cash Equivalents At Carrying Value |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Stockholders Equity | -$3.9M | -$3.0M | -$2.8M | -$54.6K | -$40.6K | $2.7K |
| Retained Earnings Accumulated Deficit | -$3.9M | -$3.0M | -$2.8M | |||
| Liabilities And Stockholders Equity | $205.7M | $203.7M | $201.5M | |||
| Assets | $205.7M | $203.7M | $201.5M | |||
| Liabilities | $1.2M | $330.7K | $144.6K | |||
| Accrued Liabilities Current | $320.5K | $86.8K | $144.6K | |||
| Temporary Equity Accretion To Redemption Value | $2.1M | $2.1M | $8.7M | |||
| Repayments Of Related Party Debt | $113.1K | |||||
| Repayments Of Notes Payable | $134.2K | |||||
| Liabilities Current | $650.7K | |||||
| Deferred Offering Costs Included In Accrued Expenses | $231.8K | |||||
| Deferred Costs | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $275.4K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $25.0K | $25.0K | $275.4K | |||
| Assets Held In Trust Noncurrent | $205.5M | $203.3M | $201.2M | |||
| Assets Current | $233.9K | $255.3K | $340.5K | |||
| Other Assets Noncurrent | $50.2K | $96.9K | ||||
| Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 | ||||||
| Forward Sale Securities Liability | $569.8K | |||||
| Noncash Or Part Noncash Acquisition Deferred Offering Costs Included In Accrued Expenses | ||||||
| Deferred Costs Current | ||||||
| Cash And Cash Equivalents At Carrying Value | $275.4K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Increase Decrease In Prepaid Expense | -$271.7K | -$2.7K | -$3.5K |
| Proceeds From Issuance Initial Public Offering | $200.0M | $200.0M | |
| Increase Decrease In Deferred Charges | -$217.6K | $217.6K | |
| Increase Decrease In Accrued Liabilities | $149.8K | $165.0K | |
| Net Cash Provided By Used In Operating Activities | $52.6K | -$134.2K | |
| Net Cash Provided By Used In Financing Activities | $200.0M | $134.2K | |
| Proceeds From Repayments Of Related Party Debt | $485.5K | $134.2K | |
| Proceeds From Issuance Of Private Placement | $5.0M | ||
| Payments To Acquire Investments | $200.0M | ||
| Net Cash Provided By Used In Investing Activities | -$200.0M | ||
| Increase Decrease In Other Operating Assets | $3.5K | ||
| Proceeds From Notes Payable | $134.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 |
|---|---|
| Increase Decrease In Prepaid Expense | $65.1K |
| Proceeds From Issuance Initial Public Offering | $200.0M |
| Increase Decrease In Deferred Charges | -$217.6K |
| Increase Decrease In Accrued Liabilities | -$20.4K |
| Net Cash Provided By Used In Operating Activities | $52.6K |
| Net Cash Provided By Used In Financing Activities | $200.2M |
| Proceeds From Repayments Of Related Party Debt | |
| Proceeds From Issuance Of Private Placement | $5.0M |
| Payments To Acquire Investments | $200.0M |
| Net Cash Provided By Used In Investing Activities | -$200.0M |
| Increase Decrease In Other Operating Assets | |
| Proceeds From Notes Payable |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 5.0M | 5.0M | |
| Weighted Average Number Of Diluted Shares Outstanding | 5.0M | 5.0M | |
| Earnings Per Share Diluted | $-0.02 | $0.00 | |
| Earnings Per Share Basic | $-0.02 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | |||
| Weighted Average Number Of Diluted Shares Outstanding | |||
| Earnings Per Share Diluted | |||
| Earnings Per Share Basic |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Investment Income Interest | $7.5M | ||
| Administrative Fees Expense | $118.1K | ||
| Additional Paid In Capital | $24.5K | $24.5K | |
| Prepaid Expense Current | $186.7K | $2.7K | |
| Stock Issued During Period Value New Issues | $5.0M | ||
| Payment Of Financing And Stock Issuance Costs | $4.3M | ||
| Costs And Expenses Related Party | $390.5K | ||
| Change In Fair Value Of Forward Sale Securities | -$13.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Investment Income Interest | $2.1M | $2.1M | $1.2M |
| Administrative Fees Expense | $30.0K | $30.0K | $28.1K |
| Additional Paid In Capital | |||
| Prepaid Expense Current | $208.5K | $230.3K | $65.1K |
| Stock Issued During Period Value New Issues | $5.0M | ||
| Payment Of Financing And Stock Issuance Costs | $4.3M | ||
| Costs And Expenses Related Party | $113.1K | ||
| Change In Fair Value Of Forward Sale Securities | -$569.8K |
Most recent annual filing with the SEC: March 2, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.